← Leaderboards
Stanley L Evans
Meharry Medical College
$200,768
Attributed
$200,768
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$200,768 · 1
By mechanism
G12$200,768 · 1
Top collaborators
No co-investigators on record.
Most similar at Meharry Medical College
Same institution · by research overlap
- Samuel E. Adunyah$29,919,724
- Fernando Villalta$13,456,705
- John E Maupin$61,813,990
- Hubert K. Rucker$3,718,985
- Chin-Ho Chen$11,542,647
Others in their field
Top investigators on “Aids”
- Judith S. Currier · University Of California Los Angeles$495,238,846
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$400,385,565
- Lawrence Corey · Fred Hutchinson Cancer Center$397,189,786
- David Heimbrook · Leidos Biomedical Research, Inc.$340,483,893
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$316,384,846
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$310,253,675
Research focus
AidsBiological ProductsBiotechnologyDrug /AgentHematologyImmunologyInfectionInflammationLymphatic SystemMinority Institution Research SupportStructural BiologyVirus
Grant awards (4)
A10: SYNTHESIS OF NON NUCLEOSIDIC ANTIVIRAL AGENTS: HIV &CANCER DRUG DESIGN$0
G12 · FY2002 · RR
A10: SYNTHESIS OF NON NUCLEOSIDIC ANTIVIRAL AGENTS: HIV &CANCER DRUG DESIGN$0
G12 · FY2002 · RR
A10: SYNTHESIS OF NON NUCLEOSIDIC ANTIVIRAL AGENTS: HIV &CANCER DRUG DESIGN$200,768
G12 · FY2001 · RR
A10: SYNTHESIS OF NON NUCLEOSIDIC ANTIVIRAL AGENTS: HIV &CANCER DRUG DESIGN$0
G12 · FY2001 · RR